Pot Stock Weakness Scuttles MedMen’s Acquisition of PharmaCann

(Bloomberg) -- The weakness in pot stocks has scuttled MedMen Enterprises Inc.’s planned acquisition of PharmaCann LLC less than a month after it received antitrust approval.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.